Next Article in Journal
Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy
Next Article in Special Issue
Resistance-Related l-Pyroglutamic Acid Affects the Biosynthesis of Trichothecenes and Phenylpropanoids by F. graminearum Sensu Stricto
Previous Article in Journal
Assessing the Aflatoxin B1 Adsorption Capacity between Biosorbents Using an In Vitro Multicompartmental Model Simulating the Dynamic Conditions in the Gastrointestinal Tract of Poultry
Previous Article in Special Issue
Dose and Exposure Time-Dependent Renal and Hepatic Effects of Intraperitoneally Administered Fumonisin B1 in Rats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Enhancing the Production of the Fungal Pigment Aurofusarin in Fusarium graminearum

by
Klaus Ringsborg Westphal
1,
Rasmus Dam Wollenberg
1,
Florian-Alexander Herbst
1,
Jens Laurids Sørensen
2,
Teis Esben Sondergaard
1 and
Reinhard Wimmer
1,*
1
Department of Chemistry and Bioscience, Aalborg University, 9220 Aalborg, Denmark
2
Department of Chemistry and Bioscience, Aalborg University, 6700 Esbjerg, Denmark
*
Author to whom correspondence should be addressed.
Toxins 2018, 10(11), 485; https://doi.org/10.3390/toxins10110485
Submission received: 30 October 2018 / Revised: 15 November 2018 / Accepted: 18 November 2018 / Published: 21 November 2018
(This article belongs to the Collection Fusarium Toxins – Relevance for Human and Animal Health)

Abstract

:
There is an increasing demand for products from natural sources, which includes a growing market for naturally-produced colorants. Filamentous fungi produce a vast number of chemically diverse pigments and are therefore explored as an easily accessible source. In this study we examine the positive regulatory effect of the transcription factor AurR1 on the aurofusarin gene cluster in Fusarium graminearum. Proteomic analyses showed that overexpression of AurR1 resulted in a significant increase of five of the eleven proteins belonging to the aurofusarin biosynthetic pathway. Further, the production of aurofusarin was increased more than threefold in the overexpression mutant compared to the wild type, reaching levels of 270 mg/L. In addition to biosynthesis of aurofusarin, several yet undescribed putative naphthoquinone/anthraquinone analogue compounds were observed in the overexpression mutant. Our results suggest that it is possible to enhance the aurofusarin production through genetic engineering.
Key Contribution: Overexpression of the transcription factor AurR1 results in tripled production of aurofusarin.

1. Introduction

The fungal polyketides are a diverse group of natural products that comprises of mycotoxins, clinical important drugs, and pigments [1,2,3]. Examples of the first two are fusarielins and lovastatin, which are shown to stimulate MCF-7 cell proliferation or commercially used against hypercholesterolemia, respectively [4,5,6]. The pigment aurofusarin, which is the target of this study, is a homodimeric naphthoquinone produced by crop molds of the genus Fusarium and is often associated with naturally infected wheat where the compound can occur in high levels [7].
Aurofusarin was initially described in 1937 as a golden yellow micro-crystalline pigment but the chemical structure was not elucidated until 1966 [8,9,10,11]. The PKS12 gene cluster from Fusarium graminearum was identified to be responsible for aurofusarin biosynthesis under the control of the local transcription factor AurR1 [12,13]. Kim and colleagues showed that the knock-out of aurR1 resulted in complete absence of pigmentation and that re-integration of a constitutively expressed aurR1 gene into the knock-out mutant led to increased aurofusarin production compared to the wild-type (wt) [12].
Besides aurR1, the PKS12 gene cluster contains ten genes encoding a polyketide synthase (PKS12), a rubrofusarin pump (AurT), a laccase not required for aurofusarin production (AurL2), a second transcription factor (AurR2), and six tailoring enzymes [14]. The transcription factor AurR2 possibly acts as a co-regulator of the PKS12 gene cluster. Deletion of aurR2 results in an altered ratio of rubrofusarin to aurofusarin [14].
The PKS12 gene cluster is responsible for the production of several other compounds including YWA1, rubrofusarin, and fuscofusarin [15,16]. The aurofusarin biosynthetic pathway can be redirected to produce citreoisocoumarin by changing nitrogen sources and pH [17]. Further, the laccase catalyzing monomeric activation resulting in radical-mediated dimerization could potentially lead to several other dimerization patterns than that present in aurofusarin [14].
Naphthoquinones, including dimeric naphthoquinones, have previously been described as having antibiotic activity against both Gram-positive and Gram-negative bacteria, as well as yeast of the genus Candida [18,19]. In fact, 22 naphthoquinones from F. solani and F. oxysporum were examined by Baker and colleagues, of which 12 were antimicrobial against Streptococcus pyogenes and 15 were active against Staphylococcus aureus [20]. Aurofusarin was shown to inhibit probiotic bacteria, which might shift the gut microbes to a more harmful constitution causing illness and diarrhea [21]. Also, aurofusarin is cytotoxic, genotoxic, and induces oxidative stress in human colon cells [22].
Cytotoxicity and antibiotic activity of naphthoquinones from the PKS12 pathway of F. graminearum should be more thoroughly investigated, including animal trials to assess aurofusarin’s antibacterial/toxicological effect when ingested through feed. However, this requires large quantities of the compound, which is very expensive. To accommodate this, we aimed to make aurofusarin and derivatives thereof more readily available. The wt F. graminearum produces aurofusarin under several growth conditions, often as one of the most abundant secondary metabolites. Therefore, we chose an over-expression strategy that contributed to the natural expression machinery by additionally expressing the aurR1 gene in an ectopic position close to the β-tubulin locus. Furthermore, we describe a method for pigment extraction directly from liquid growth media, resulting in the detection of four putative yet undescribed naphthoquinones.

2. Results and Discussion

AurR1 is a positive-acting transcription factor, influencing the expression of several genes in the aurofusarin gene cluster. To investigate the upregulation of the PKS12 gene cluster, the transcription factor aurR1 was expressed in an ectopic position next to the β-tubulin gene. The transcription factor was under control of the constitutive TEF promotor. The resulting OE::aurR1 mutant was sequenced to approximately 200× coverage (Supplementary Figure S1) to verify the correct integration of the insert. To determine the protein expression level, protein was extracted from dried mycelial powder of both OE::aurR1 and the wt and analyzed using shotgun proteomics. Seven out of ten proteins from the aurofusarin gene cluster were detected, of which five showed significantly increased expression (p < 0.05) in the OE::aurR1 mutant when comparing label-free quantification (LFQ) values (Table 1 and Figure 1a) [23]. We also compared three housekeeping genes to evaluate the performance of the method for which we observed no difference between the mutant and the wt. These were β-tubulin (UniProt ID: I1RR95), H+-ATPase (UniProt ID: I1RCU4), and TEF-1α (UniProt ID: I1R.W.X5) with p-values calculated to be 0.4, 0.5, and 0.5, respectively (Figure 1b). The p-value for AurZ was calculated to be 0.07 and was therefore slightly above the threshold for statistical significance. However, two out of three LFQ values for AurZ in the wt were imputed to reflect low abundant proteins, which might have caused an overestimation of the actual p-value [24]. There was no statistical significant difference in expression for AurT (p = 0.32) between the mutant and the wt, indicating either that AurR1 does not affect the transcription of aurT or, perhaps more likely, the applied method for protein extraction does not favor membrane bound proteins [25]. The mutant to the wt LFQ ratios for detected proteins from the cluster were calculated to be between 4.5 and 11.2, with the exception of AurT, which was at 1.6. Expectedly, AurR1 and AurR2 were not detected. Transcription factors are known to have unstable mRNA and proteins, both contributing to low abundance [26]. Additionally, detection of compartmentalized and DNA binding proteins, such as transcription factors, benefit from selective purification and enrichment procedures [27]. AurL2 and AurS were not detected, probably due to low abundance. It could be expected that the expression of aurL2 would not be influenced by AurR1 as it is not required for aurofusarin biosynthesis [14]. AurS contains a transmembrane helix (InterPro [28] and Pfam [29]) indicating that this protein is anchored to the cell membrane, which could lead to reduced solubility and yield in the protein extraction.
When comparing intensity-based absolute quantification (iBAQ) values, the most abundant protein from the PKS12 cluster in both the wt and the mutant was AurO closely followed by AurJ (Figure 2) [26]. In the mutant, these two proteins are expressed as the sixth and eighth most abundant within the 908 proteins quantified. Comparing OE::aurR1 and the wt, all observed proteins of the PKS12 cluster have become more abundant compared to other cellular proteins. If one sorts the proteins or the PKS12 cluster by abundance, their relative order is maintained when going from the wt to OE::aurR1, with the exception of AurF which went from sixth in the wt to third in the mutant. As the p-values in Table 1 already indicate, there is no significant difference in expression for AurT between the mutant and the wt. Either AurR1 does not affect the expression of aurT, or AurR1 affects the expression of aurT, albeit to a lesser extent compared to the other proteins in the cluster.
The phenotype of the OE::aurR1 mutant appeared deep red with yellow aerial mycelium when grown for six days on a solid Cz medium (Figure 3a) compared to the wt, which was pale red/pink with white aerial mycelium. An aurR1 knockout mutant previously described by Frandsen and colleagues in 2006 was cultured simultaneously and, as expected, exhibited complete lack of coloration [14]. Cultures of OE::aurR1 and the wt were grown in liquid Cz medium for three days, at which point a clear difference in coloration was observed (Figure 3b). The wt culture was pale-yellowish while the mutant displayed a dark red-brownish color. Aurofusarin, and derivatives thereof, contain conjugated systems absorbing visible light at longer wavelengths, which could explain the observed difference. Metabolites were extracted directly from the medium from two individual 1 L cultures of both the mutant and the wt grown for three days and the concentration of aurofusarin was measured using quantitative 1H-NMR. Expectedly, the mutant produced the most aurofusarin with concentrations calculated at 36.3 and 39.7 mg/L compared to 8.9 and 13.7 mg/L for the wt. The mutant thereby produced between 2.6 and 3.4 times more aurofusarin than the wt, supporting the proteomics data.
The final step in the aurofusarin biosynthetic pathway is a dimerization of rubrofusarin to aurofusarin, which is predicted to be catalyzed by an extracellular enzyme complex consisting of Gip1, AurF, AurO, and AurS [15]. Gip1 is a predicted laccase with a multicopper oxidase domain and we therefore hypothesized that the availability of copper ions could influence aurofusarin production in the overexpression mutant. However, ranging the concentration from 10 to 80 µM CuSO4 × 5H2O did not significantly affect aurofusarin production. The highest average production was observed at 10 µM CuSO4 × 5H2O, which yielded 270 mg/L aurofusarin after seven days of growth (Supplementary Figure S2).
The extracted compounds from the OE::aurR1 culture were analyzed using HPLC-DAD-HRMS (Figure 4). Five peaks (A-E) were observed from a UV chromatogram (400 nm) with UV spectra similar to that of aurofusarin (spectrum B). The UV spectrum of aurofusarin has two peak maxima at 244 and 268 nm and a broad peak at 381 nm, with a UV(244)/UV(268) absorption ratio around 1.5. A similar ratio was observed for peak A; however, the ratio had shifted to 0.9 for peak C. The absorption ratios for peak D and E were calculated at 0.6 and 0.4, respectively. Eleven masses were observed, which corresponded to compounds with chemical formulae comparable to that of aurofusarin or possible analogues (Table 2). Peak B had a [M + H]+ at 571.09 Da corresponding to aurofusarin. Further, the [M + H]+ for peak D was measured at 557.11 Da corresponding to fuscofusarin. Peak A aligned with a [M + H]+ of 557.07 Da fitting the chemical formula C29H16O12, which is comparable to that of aurofusarin with the loss of CH2. This could be explained by one of the monomers of aurofusarin lacking an O-methylation, which could also explain the lower retention time. Peak C was measured at 573.10 Da [M + H]+ corresponding to aurofusarin with an increased mass of two hydrogens. Finally, peak E had a mass at 543.13 giving a chemical formula of C30H22O10. Compared to aurofusarin, this compound has an increase of four hydrogen atoms and a loss of two oxygen atoms. This could be explained by a homodimerization of rubrofusarin, which was also proposed by Frandsen in 2006 [14]. The remaining six masses [M + H]+ were measured at 587.08 Da (C30H18O13, aurofusarin + O), 603.08 Da (C30H18O14, aurofusarin + 2O), 589.10 Da (C30H20O13, aurofusarin + H2O), 575.12 Da (C30H22O12, aurofusarin + 4H), 541.08 (C29H16O11, aurofusarin − CH2O), and 273.08 Da (rubrofusarin). When over-expressing a local transcription factor from a secondary metabolite cluster, it could be expected that the natural ratio and abundance of modifying enzymes was changed, which might result in alternative routes for the biosynthetic machinery. This could explain the proposed naphthoquinone derivatives observed from the OE::aurR1 metabolite extract. A database search for known naphthoquinone/anthraquinone natural products employing Reaxys and PubChem could not identify any possible candidates for peaks 1–4 indicating that these might be yet undescribed compounds.

3. Conclusions

In the present study, we have described the changes of protein expression and secondary metabolite production when the local transcription factor AurR1 is over-produced. Five of the seven detected proteins from the PKS12 cluster were observed to be significantly increased in the AurR1 over-producing mutant. In general, all proteins from the cluster were more abundant relative to the total cell protein in the mutant compared to the wt; however, the transporter AurT was affected to a lesser extent. The mutant produced between 2.6 and 3.4 times the amount of aurofusarin compared to the wild type with a maximal observed mean production of 270 mg/L. The availability of copper ions did not affect aurofusarin production, but future studies with other factors, such as a nitrogen and carbon source, temperature, and aeration can perhaps be more successful. The mutant was shown to produce several compounds with chemical formulae comparable to aurofusarin analogues, four of which had no match to known naphthoquinone/anthraquinone natural products. The extraction of aurofusarin and related compounds directly from the media enabled faster and more efficient production of aurofusarin, which could easily be implemented to flow reactors.

4. Materials and Methods

4.1. Generation and Verification of aurR1 Overexpression Mutant

aurR1 (FGSG_02320) was amplified using PCR using the primers PaurR1_Fw (5′-ACGTCGGATCCATGAGTTCCACAGACCCCCTTCT-3′) and PaurR1_Rv (5′-ACGTCTCTAGACTACTTGACCTCGAGCTTCTTTCGT-3′) (Eurofins Genomics, Ebersberg, Germany) holding restriction sites for BamHI and XbaI, respectively. PCR was conducted with PfuTurbo Cx Hotstart DNA Polymerase (Agilent, Santa Clara, CA, USA) using genomic DNA from F. graminearum PH-1 (NRRL 31084) as a template. The amplified aurR1 PCR fragment was cloned into a U-GOTL vector, which is a modified version of the U-GOAL vector [30]. The U-GOTL vector has border regions targeting the β-tubulin locus. The cloned vector was verified using colony PCR and sequencing of the integrated site by Eurofins Genomics.
The vector was electroporated into Agrobacterium tumefaciens LBA4404 obtained from Invitrogen, Thermo Fisher Scientific Inc. catalog number: 18313-015, which was subsequently used to transform macroconidia of F. graminearum as previously described [31]. The macroconidia were obtained from a 5-day culture grown in a carboxymethylcellulose medium (CMC) (15 g/L sodium carboxymethylcellulose medium viscosity (MP Biomedicals, Solon, OH, USA), 1 g/L NH4NO3, 1 g/L KH2PO4, 0.5 g/L MgSO4·7H2O, 1 g/L yeast extract (Difco Lboratories, Detroit, MI, USA)) in the dark at 20 °C with 150 rpm. The aurR1 overexpression mutants were selected for by growing on a defined Fusarium medium containing 300 µg/mL of geneticin (Sigma-Aldritch, St. Louis, MO, USA), and the correct insertion of the aurR1 gene was verified by full genome sequencing.
Fungal DNA was extracted with the FastDNA SPIN Kit for Soil (MP Biomedicals) and cleaned with Agencourt AMPure XP beads (Beckman Coulter, Brea, CA, USA).
A Nextera paired-end DNA library (Illumina, San Diego, CA, USA) was prepared according to the manufacturers description, with the modification of using Agencourt AMPure XP beads (0.7 bead:sample ratio) for the post-tagmentation clean-up. The quality of the purified DNA was measured using a NanoDrop ND-1000 (Thermo Scientific, Waltham, MA, USA), a D1000 ScreenTape system (Agilent, Santa Clara, CA, USA), and using the Qubit dsDNA HS assay kit (Thermo Scientific, USA).
The paired-end library was sequenced to approximately 200× coverage on the Illumina HiSeq 2500 system using the Rapid SBS Kit v2 (2 × 250 cycles). The data were trimmed for low quality reads, ambiguous nucleotides, and adaptors in CLC Genomics Workbench v. 9.4.2 (Qiagen, Vedbæk, Denmark). Following read-merging, reads were mapped to a reference genome (PH1) and further assessed for random insertion using a de novo assembly approach.

4.2. Proteomics

Triplicate cultures of OE::aurR1 and the wild type were grown in Liquid Czapek Dox (Cz) medium (30 g/L sucrose, 3 g/L NaNO3, 1 g/L K2HPO4, 0.5 g/L MgSO4·7H2O, 0.5 g/L KCl, 0.01 g/L FeSO4·7H2O, 16 mg/L ZnSO4·7H2O, 5 mg/L CuSO4·5H2O, pH 6.25) at 25 °C with 100 rpm for five days. The cultures were filtered through MiraCloth (Calbiochem, Merck, Darmstadt, Germany) and the fungal mycelium was lyophilized. Protein concentration was determined from 10 mg of dried fungal powder suspended in 500 µL of cold sterile H2O. The solution was heated to 95 °C for 10 min and afterwards cooled on ice. The samples were centrifuged for 5 min at 14,100× g, and the supernatant was transferred to new tubes. The samples were centrifuged a second time for 5 min at 14,100× g and the protein concentration was measured using Qubit.
Samples for the proteomic analyses were processed using a polyvinylidene fluoride membrane-based proteomic sample preparation approach as described elsewhere [32]. In short, approximately 20 µg of protein was suspended in urea buffer for denaturation, and was reduced and carbamidomethylated before in-solution trypsin digestion. Clean-up was performed by washing and elution from the membrane. Tryptic peptides were measured using nLC-MS/MS (Ultimate 3000 coupled to a Q Exactive, Thermo Fisher Scientific, Waltham, MA, USA) applying a 3 h method (≈140 min elution window), where details can be found elsewhere [33]. Mass spectra were analyzed using MaxQuant (version 1.5.3.30, Max Planck Institute of Biochemistry, Martinsried, Germany) [34] as previously described [33]. Besides activation of label-free quantification by the MaxQuant label-free quantification algorithm [35] and iBAQ calculations [26], settings were kept on default. This includes a false-discovery rate of maximum 1% on peptide and protein level. An organism-specific protein database in FASTA file format was obtained from UniProt [36].
The LFQ and iBAQ data matrix’s were imported into Perseus (version 1.5.6.0, Max Planck Institute of Biochemistry, Martinsried, Germany) [37] and grouped into either OE::aurR1 or wt. The data was filtered to remove proteins that were only identified by site, reverse, and potential contaminants. Further, all proteins must be represented by at least two valid values larger than 0 in at least one of the groups. The values were log2(x) transformed, and missing values were imputed from a normal distribution of the whole matrix using a width of 0.3 and a downshift of 1.8 to represent low abundant proteins. A two-tailed Student’s t-test was applied to determine whether protein concentration levels differed significantly between the OE::aurR1 and wild type cultures. Statistical significance was defined as a p-value ≤ 0.05.

4.3. Metabolite Extraction from Liquid Growth Medium, NMR Quantification, and LCMS

One L Cz media was inoculated with 5 × 103 spores of OE::aurR1 or the wild type and incubated in a 2 L Erlenmeyer flask with three baffles at 25 °C and 100 rpm for 3 days in complete darkness, both in duplicates. The growth media was filtrated through Miracloth. 300 mL media in a 1 L bluecap bottle, and was acidified with 20 mL 5 M HCl and shaken. The color of the media was observed to change from dark brown to yellow. Three hundred milliliters of chloroform was added and the mixture was shaken. After settling, the color could be observed in the water phase. Two hundred milliliters of methanol was added and the mixture was shaken vigorously. The phases were allowed to settle and a yellow coloration was now observed in the organic phase. Most of the water phase was carefully decanted. Two hundred milliliters of 10% w/v NaCl in demineralized water was added to the chloroform together with 100 mL of methanol. The mixture was shaken and the phases were allowed to settle. The organic phase was collected using a separating funnel. The solvent was removed using rotary evaporation in vacuo at 40 °C.
The dried metabolite extracts were re-dissolved in 12 mL of chloroform and analyzed using LC-MS. Sixty microliters of each sample were dried under N2 gas and dissolved in 600 µL chloroform-d (99.8 atom % D, 0.03% TMS, Euriso-Top GmbH, Saarbrücken, Germany) and analysed by NMR.
1H and 1H-PULCON [38] spectra were recorded on a Bruker AVIII-600 MHz spectrometer (Bruker, Karlsruhe, Germany) equipped with a triple resonance cryogenically cooled probe with z-gradients and controlled by TopSpin 3.5pl6. All recordings were performed in chloroform-d at 298.1 K and calibrated to TMS 1H (0 ppm).
Extracts from OE::aurR1 were analyzed using HPLC-DAD-HRMS on a Hitachi Elite LaChrom HPLC system (Hitachi Ltd., Tokyo, Japan) equipped with an L-2130 pump, L-2200 autosampler, L-2300 column oven at 40 °C with a C6-phenyl column (150 × 4.6 mm Ascentis Xpress 2.7 μm, Sigma-Aldrich, St. Louis, MO, USA), and an L-2450 DAD detector. The system was coupled through a 5:95 flowsplitter to a high-resolution mass spectrometer (Compact qTOF, Bruker, Karlsruhe, Germany) with an electrospray source (Capilary: 4500 V; end plate offset 500 V; dry gas 4.0 L/min, 200 °C) and run in positive mode. The 1 mL/min gradient initiated at 90% solvent A (water, HiPerSolv, VWR, Radnor, PA, USA) and 10% solvent B (acetonitrile, Hypersolve, VWR, Radnor, PA, USA), were both supplemented with 0.1% formic acid (MS grade 98%, Sigma-Aldrich), increasing linearly to 100% solvent B over 20 min and held for 5 min. Twelve seconds after sample injection, a 2 µL calibrant solution (10 mM NaOH and 26 mM formic acid in 1:1 MS-grade H2O:isopropanol) was injected into the mass spectrometer.

4.4. Production of Aurofusarin in Response to Copper Availability

Prior to experiments, spores of OE::aurR1 were produced in 50 mL of liquid CMC medium by shaking at 150 rpm and 20 °C for four days [39]. The macroconidia were resuspended in sterile H2O after two rounds of centrifugation to reach a concentration of 3.5 × 106/mL. One hundred microliters of the spore solution was added to 250 mL baffled flasks containing 100 mL of Czapek dox medium [40] to which 0.1 mL ZnSO4 × 7 H2O (1 g/100 mL) was added together with 0.1 mL CuSO4 × 5 H2O (0.25, 0.5, 1, 2, 3, or 4 g/100 mL). The flasks were incubated in a dark shaking incubator at 120 rpm for one week at 25 °C.
To determine the aurofusarin production, 1 mL of medium was transferred to a micro centrifuge tube and spun for two minutes at 12,000 rpm to remove impurities. A 10 µL sample was then transferred to an HPLC vial and diluted with 990 µL of methanol. Aurofusarin was quantified using HPLC-MS/MS as given previously using a two-fold dilution series ranging from 0.019–10 mg/L [41,42].

Supplementary Materials

The following are available online at https://www.mdpi.com/2072-6651/10/11/485/s1, Figure S1: Sequencing results for the OE::aurR1 mutant, Figure S2: Production of aurofusarin in the OE::aurR1 mutant in response to variable concentration of copper.

Author Contributions

Conceptualization, K.R.W., J.L.S., T.E.S. and R.W.; methodology, K.R.W., T.E.S. and F.-A.H.; validation, K.R.W. and R.D.W.; formal analysis, K.R.W., F.-A.H. and J.L.S.; investigation, K.R.W., F.-A.H., and J.L.S.; resources, J.L.S., T.E.S. and R.W.; writing—original draft preparation, K.R.W.; writing—review and editing, all authors.; visualization, K.R.W.; supervision, T.E.S., J.L.S. and R.W.; project administration, T.E.S. and R.W.; funding acquisition, T.E.S. and R.W.

Funding

This research was funded by the NovoNordisk Foundation (grant NNF15OC0016186). The NMR laboratory at Aalborg University is supported by the Obel Family, SparNord, and Carlsberg Foundations.

Acknowledgments

We would like to thank Rasmus J.N. Frandsen for the generation of the KO::aurR1 mutant.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sayyed, I.; Majumder, D.R. Pigment Production from Fungi. Int. J. Curr. Microbiol. Appl. Sci. 2015, 2, 103–109. [Google Scholar]
  2. Peraica, M.; Radić, B.; Lucić, A.; Pavlović, M. Toxic effects of mycotoxins in humans. Bull. World Health Organ. 1999, 77, 754–766. [Google Scholar] [CrossRef] [PubMed]
  3. Aly, A.H.; Debbab, A.; Proksch, P. Fifty years of drug discovery from fungi. Fungal Divers. 2011, 50, 3–19. [Google Scholar] [CrossRef]
  4. Sondergaard, T.E.; Klitgaard, L.G.; Purup, S.; Kobayashi, H.; Giese, H.; Sørensen, J.L. Estrogenic effects of fusarielins in human breast cancer cell lines. Toxicol. Lett. 2012, 214, 259–262. [Google Scholar] [CrossRef] [PubMed]
  5. McKenney, J.M. Lovastatin: A new cholesterol-lowering agent. Clin. Pharm. 1988, 7, 21–36. [Google Scholar] [PubMed]
  6. Henwood, J.M.; Heel, R.C. Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia. Drugs 1988, 36, 429–454. [Google Scholar] [CrossRef] [PubMed]
  7. Streit, E.; Naehrer, K.; Rodrigues, I.; Schatzmayr, G. Mycotoxin occurrence in feed and feed raw materials worldwide: Long-term analysis with special focus on Europe and Asia. J. Sci. Food Agric. 2013, 93, 2892–2899. [Google Scholar] [CrossRef] [PubMed]
  8. Ashley, J.N.; Hobbs, B.C.; Raistrick, H. Studies in the biochemistry of micro-organisms: The crystalline colouring matters of Fusarium culmorum (W. G. Smith) Sacc. and related forms. Biochem. J. 1937, 31, 385–397. [Google Scholar] [CrossRef] [PubMed]
  9. Shibata, S.; Morishita, E.; Takeda, T.; Sakata, K. The structure of aurofusarin. Tetrahedron Lett. 1966, 7, 4855–4860. [Google Scholar] [CrossRef]
  10. Baker, P.M.; Roberts, J.C. Studies in mycological chemistry. Part XXI. The structure of aurofusarin, a metabolite of some Fusarium species. J. Chem. Soc. C 1966, 2234–2237. [Google Scholar] [CrossRef]
  11. Shibata, S.; Morishita, E.; Takeda, T.; Sakata, K. Metabolic Products of Fungi. XXVIII. The Structure of Aurofusarin. (2). Chem. Pharm. Bull. 1968, 16, 405–410. [Google Scholar] [CrossRef]
  12. Kim, J.E.; Jin, J.; Kim, H.; Kim, J.-C.; Yun, S.; Lee, Y. GIP2, a Putative Transcription Factor That Regulates the Aurofusarin Biosynthetic Gene Cluster in Gibberella zeae. Appl. Environ. Microbiol. 2006, 72, 1645–1652. [Google Scholar] [CrossRef] [PubMed]
  13. Malz, S.; Grell, M.N.; Thrane, C.; Maier, F.J.; Rosager, P.; Felk, A.; Albertsen, K.S.; Salomon, S.; Bohn, L.; Schäfer, W.; et al. Identification of a gene cluster responsible for the biosynthesis of aurofusarin in the Fusarium graminearum species complex. Fungal Genet. Biol. 2005, 42, 420–433. [Google Scholar] [CrossRef] [PubMed]
  14. Frandsen, R.J.N.; Nielsen, N.J.; Maolanon, N.; Sørensen, J.C.; Olsson, S.; Nielsen, J.; Giese, H. The biosynthetic pathway for aurofusarin in Fusarium graminearum reveals a close link between the naphthoquinones and naphthopyrones. Mol. Microbiol. 2006, 61, 1069–1080. [Google Scholar] [CrossRef] [PubMed]
  15. Frandsen, R.J.N.; Schütt, C.; Lund, B.W.; Staerk, D.; Nielsen, J.; Olsson, S.; Giese, H. Two novel classes of enzymes are required for the biosynthesis of aurofusarin in Fusarium graminearum. J. Biol. Chem. 2011, 286, 10419–10428. [Google Scholar] [CrossRef] [PubMed]
  16. Klitgaard, A.; Frandsen, R.J.N.; Holm, D.K.; Knudsen, P.B.; Frisvad, J.C.; Nielsen, K.F. Combining UHPLC-High Resolution MS and Feeding of Stable Isotope Labeled Polyketide Intermediates for Linking Precursors to End Products. J. Nat. Prod. 2015, 78, 1518–1525. [Google Scholar] [CrossRef] [PubMed]
  17. Sørensen, J.L.; Nielsen, K.F.; Sondergaard, T.E. Redirection of pigment biosynthesis to isocoumarins in Fusarium. Fungal Genet. Biol. 2012, 49, 613–618. [Google Scholar] [CrossRef] [PubMed]
  18. Medentsev, A.G.; Akimenko, V.K. Naphthoquinone metabolites of the fungi. Phytochemistry 1998, 47, 935–959. [Google Scholar] [CrossRef]
  19. Futuro, D.O.; Ferreira, P.G.; Nicoletti, C.D.; Borba-Santos, L.P.; Da Silva, F.C.; Rozental, S.; Ferreira, V.F. The antifungal activity of naphthoquinones: An integrative review. An. Acad. Bras. Cienc. 2018, 90, 1187–1214. [Google Scholar] [CrossRef] [PubMed]
  20. Baker, R.A.; Tatum, J.H.; Nemec, S. Antimicrobial activity of naphthoquinones from Fusaria. Mycopathologia 1990, 111, 9–15. [Google Scholar] [CrossRef] [PubMed]
  21. Sondergaard, T.E.; Fredborg, M.; Oppenhagen Christensen, A.M.; Damsgaard, S.K.; Kramer, N.F.; Giese, H.; Sørensen, J.L. Fast Screening of Antibacterial Compounds from Fusaria. Toxins 2016, 8, 355. [Google Scholar] [CrossRef] [PubMed]
  22. Jarolim, K.; Wolters, K.; Woelflingseder, L.; Pahlke, G.; Beisl, J.; Puntscher, H.; Braun, D.; Sulyok, M.; Warth, B.; Marko, D. The secondary Fusarium metabolite aurofusarin induces oxidative stress, cytotoxicity and genotoxicity in human colon cells. Toxicol. Lett. 2018, 284, 170–183. [Google Scholar] [CrossRef] [PubMed]
  23. Cox, J.; Mann, M. Quantitative, High-Resolution Proteomics for Data-Driven Systems Biology. Annu. Rev. Biochem. 2011, 80, 273–299. [Google Scholar] [CrossRef] [PubMed]
  24. Lazar, C.; Gatto, L.; Ferro, M.; Bruley, C.; Burger, T. Accounting for the Multiple Natures of Missing Values in Label-Free Quantitative Proteomics Data Sets to Compare Imputation Strategies. J. Proteome Res. 2016, 15, 1116–1125. [Google Scholar] [CrossRef] [PubMed]
  25. Smith, S.M. Strategies for the purification of membrane proteins. Methods Mol. Biol. 2011, 681, 485–496. [Google Scholar] [CrossRef] [PubMed]
  26. Schwanhüusser, B.; Busse, D.; Li, N.; Dittmar, G.; Schuchhardt, J.; Wolf, J.; Chen, W.; Selbach, M. Global quantification of mammalian gene expression control. Nature 2011, 473, 337–342. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Zhou, F.; Lu, Y.; Ficarro, S.B.; Adelmant, G.; Jiang, W.; Luckey, C.J.; Marto, J.A. Genome-scale proteome quantification by DEEP SEQ mass spectrometry. Nat. Commun. 2013, 4, 3171. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Finn, R.D.; Attwood, T.K.; Babbitt, P.C.; Bateman, A.; Bork, P.; Bridge, A.J.; Chang, H.-Y.; Dosztanyi, Z.; El-Gebali, S.; Fraser, M.; et al. InterPro in 2017-beyond protein family and domain annotations. Nucleic Acids Res. 2017, 45, D190–D199. [Google Scholar] [CrossRef] [PubMed]
  29. Finn, R.D.; Coggill, P.; Eberhardt, R.Y.; Eddy, S.R.; Mistry, J.; Mitchell, A.L.; Potter, S.C.; Punta, M.; Qureshi, M.; Sangrador-Vegas, A.; et al. The Pfam protein families database: Towards a more sustainable future. Nucleic Acids Res. 2016, 44, D279–D285. [Google Scholar] [CrossRef] [PubMed]
  30. Josefsen, L.; Droce, A.; Sondergaard, T.E.; Sørensen, J.L.; Bormann, J.; Schäfer, W.; Giese, H.; Olsson, S. Autophagy provides nutrients for nonassimilating fungal structures and is necessary for plant colonization but not for infection in the necrotrophic plant pathogen Fusarium graminearum. Autophagy 2012, 8, 326–337. [Google Scholar] [CrossRef] [PubMed]
  31. Hansen, F.T.; Droce, A.; Sørensen, J.L.; Fojan, P.; Giese, H.; Sondergaard, T.E. Overexpression of NRPS4 leads to increased surface hydrophobicity in Fusarium graminearum. Fungal Biol. 2012, 116, 855–862. [Google Scholar] [CrossRef] [PubMed]
  32. Berger, S.T.; Ahmed, S.; Muntel, J.; Cuevas Polo, N.; Bachur, R.; Kentsis, A.; Steen, J.; Steen, H. MStern Blotting-High Throughput Polyvinylidene Fluoride (PVDF) Membrane-Based Proteomic Sample Preparation for 96-Well Plates. Mol. Cell. Proteomics 2015, 14, 2814–2823. [Google Scholar] [CrossRef] [PubMed]
  33. Herbst, F.-A.; Danielsen, H.N.; Wimmer, R.; Nielsen, P.H.; Dueholm, M.S. Label-free quantification reveals major proteomic changes in Pseudomonas putida F1 during the exponential growth phase. Proteomics 2015, 15, 3244–3252. [Google Scholar] [CrossRef] [PubMed]
  34. Tyanova, S.; Temu, T.; Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 2016, 11, 2301–2319. [Google Scholar] [CrossRef] [PubMed]
  35. Cox, J.; Hein, M.Y.; Luber, C.A.; Paron, I.; Nagaraj, N.; Mann, M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteom. 2014, 13, 2513–2526. [Google Scholar] [CrossRef] [PubMed]
  36. UniProt: The universal protein knowledgebase. Nucleic Acids Res. 2017, 45, D158–D169. [CrossRef] [PubMed]
  37. Tyanova, S.; Temu, T.; Sinitcyn, P.; Carlson, A.; Hein, M.Y.; Geiger, T.; Mann, M.; Cox, J. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 2016, 13, 731–740. [Google Scholar] [CrossRef] [PubMed]
  38. Wider, G.; Dreier, L. Measuring protein concentrations by NMR spectroscopy. J. Am. Chem. Soc. 2006, 128, 2571–2576. [Google Scholar] [CrossRef] [PubMed]
  39. Cappellini, R.A.; Peterson, J.L. Macroconidium Formation in Submerged Cultures by a Non-Sporulating Strain of Gibberella zeae. Mycologia 1965, 57, 962–966. [Google Scholar] [CrossRef]
  40. Leslie, J.F.; Summerell, B.A. The Fusarium Laboratory Manual, 1st ed.; Leslie, J.F., Summerell, B.A., Eds.; Blackwell Publishing Ltd.: Hoboken, NJ, USA, 2007; ISBN 9780813819198. [Google Scholar]
  41. Sørensen, J.L.; Sondergaard, T.E. The effects of different yeast extracts on secondary metabolite production in Fusarium. Int. J. Food Microbiol. 2014, 170, 55–60. [Google Scholar] [CrossRef] [PubMed]
  42. Sorensen, J.L.; Giese, H. Influence of carbohydrates on secondary metabolism in Fusarium avenaceum. Toxins 2013, 5, 1655–1663. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The PKS12 gene cluster (a) and housekeeping genes (b) with mean log2 (label-free relative quantification) intensities of identified proteins and standard error bars calculated from three biological replicates of OE::aurR1 and wt grown on Cz medium. The p-values are calculated from a two-tailed Student’s t-test. Missing/undetected values from the wild type were imputed to reflect low-abundant proteins.
Figure 1. The PKS12 gene cluster (a) and housekeeping genes (b) with mean log2 (label-free relative quantification) intensities of identified proteins and standard error bars calculated from three biological replicates of OE::aurR1 and wt grown on Cz medium. The p-values are calculated from a two-tailed Student’s t-test. Missing/undetected values from the wild type were imputed to reflect low-abundant proteins.
Toxins 10 00485 g001
Figure 2. Scatter plots of 908 identified proteins sorted from highest to lowest log2 (intensity-based absolute quantification) intensities calculated from three biological replicates of OE::aurR1 and the wt grown on a Cz medium. The proteins from the PKS12 gene cluster are highlighted and the dotted lines show the correlation between OE::aurR1 and the wt. The wt plot is downshifted by five log2 units.
Figure 2. Scatter plots of 908 identified proteins sorted from highest to lowest log2 (intensity-based absolute quantification) intensities calculated from three biological replicates of OE::aurR1 and the wt grown on a Cz medium. The proteins from the PKS12 gene cluster are highlighted and the dotted lines show the correlation between OE::aurR1 and the wt. The wt plot is downshifted by five log2 units.
Toxins 10 00485 g002
Figure 3. Color differences of wild type and mutants. (a) Wild type Fusarium graminearum (wt), aurR1 knockout mutant (KO::aurR1), and OE::aurR1 grown on a Cz agar medium for 6 days. (b) Cultures of wt and OE::aurR1 grown for 3 days in a liquid Cz medium. 1H-NMR quantification of aurofusarin from biological duplicates are indicated in mg/mL.
Figure 3. Color differences of wild type and mutants. (a) Wild type Fusarium graminearum (wt), aurR1 knockout mutant (KO::aurR1), and OE::aurR1 grown on a Cz agar medium for 6 days. (b) Cultures of wt and OE::aurR1 grown for 3 days in a liquid Cz medium. 1H-NMR quantification of aurofusarin from biological duplicates are indicated in mg/mL.
Toxins 10 00485 g003
Figure 4. Chromatograms from a metabolite extract of Cz medium 5 days after inoculation with OE::aurR1. Left: a UV 400 nm chromatogram (spectral background subtracted) with selected peaks (A–E) and underlying colored extracted ion chromatograms (EICs) of selected masses (1–11, [M + H]+ ± 0.02 Da) scaled by relative intensities. Right: UV spectra (205–600 nm) for peaks A–E.
Figure 4. Chromatograms from a metabolite extract of Cz medium 5 days after inoculation with OE::aurR1. Left: a UV 400 nm chromatogram (spectral background subtracted) with selected peaks (A–E) and underlying colored extracted ion chromatograms (EICs) of selected masses (1–11, [M + H]+ ± 0.02 Da) scaled by relative intensities. Right: UV spectra (205–600 nm) for peaks A–E.
Toxins 10 00485 g004
Table 1. The PKS12 gene cluster in F. graminearum. Predicted protein function by Pfam or InterPro.
Table 1. The PKS12 gene cluster in F. graminearum. Predicted protein function by Pfam or InterPro.
LocusNameUniProt IDPredicted FunctionMutant (LFQ)/Wt (LFQ)
FG02320AurR1I1RF54Positive acting transcription factor
FG02321AurOI1RF55Oxidoreductase4.5
FG02322AurTI1RF56Rubrufusarin pump1.6
FG02323AurR2I1RF57Transcription factor
FG02324PKS12I1RF58Polyketide synthase producing YWA110.8
FG02325AurZI1RF59Dehydratase4.6
FG02326AurJI1RF60O-methyltransferase8.4
FG02327AurFI1RF61Monooxygenase11.2
FG02328Gip1I1RF62Cu-oxidase7.9
FG02329AurSI1RF63Fasciclin-like domain containing protein
FG02330AurL2 1I1RF64Cu-oxidase
1 Is not required for aurofusarin production.
Table 2. List of selected masses from Figure 4 number 1–11 (#) including retention time (RT), observed charged mass ([M + H]+), proposed chemical formula, and the compound name/modification relative to aurofusarin.
Table 2. List of selected masses from Figure 4 number 1–11 (#) including retention time (RT), observed charged mass ([M + H]+), proposed chemical formula, and the compound name/modification relative to aurofusarin.
#RT (min)Mass [M + H]+Chemical FormulaName/Variation
110.2; 12.9 1; 13.4; 14.3587.08202 C30H18O13+O
210.9 (A); 11.7557.07152 C29H16O12−CH2
312.5603.07692 C30H18O14+2O
412.9589.09772 C30H20O13+H2O
513.6 (B); 14.1 (C)571.0871C30H18O12aurofusarin
613.6 1 (B); 14.1 (C)573.1027C30H20O12+2H
714.11 (C); 14.7575.1184C30H22O12+4H
815.2541.0765C29H16O11−CH2O
915.7273.0758C15H12O5rubrofusarin
1015.8 (D)557.1078C30H20O11fuscofusarin
1117.7 (E)543.1286C30H22O10−2O + 4H
1 The observed EIC peak was caused by an isotopomer of a different compound or by a compound with a closely related mass. 2 Chemical formulae that does not match any natural products with a naphthoquinone/anthraquinone structure based on a Reaxys and PubChem database search.

Share and Cite

MDPI and ACS Style

Westphal, K.R.; Wollenberg, R.D.; Herbst, F.-A.; Sørensen, J.L.; Sondergaard, T.E.; Wimmer, R. Enhancing the Production of the Fungal Pigment Aurofusarin in Fusarium graminearum. Toxins 2018, 10, 485. https://doi.org/10.3390/toxins10110485

AMA Style

Westphal KR, Wollenberg RD, Herbst F-A, Sørensen JL, Sondergaard TE, Wimmer R. Enhancing the Production of the Fungal Pigment Aurofusarin in Fusarium graminearum. Toxins. 2018; 10(11):485. https://doi.org/10.3390/toxins10110485

Chicago/Turabian Style

Westphal, Klaus Ringsborg, Rasmus Dam Wollenberg, Florian-Alexander Herbst, Jens Laurids Sørensen, Teis Esben Sondergaard, and Reinhard Wimmer. 2018. "Enhancing the Production of the Fungal Pigment Aurofusarin in Fusarium graminearum" Toxins 10, no. 11: 485. https://doi.org/10.3390/toxins10110485

APA Style

Westphal, K. R., Wollenberg, R. D., Herbst, F. -A., Sørensen, J. L., Sondergaard, T. E., & Wimmer, R. (2018). Enhancing the Production of the Fungal Pigment Aurofusarin in Fusarium graminearum. Toxins, 10(11), 485. https://doi.org/10.3390/toxins10110485

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop